139 related articles for article (PubMed ID: 10881892)
1. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study.
Ylitalo N; Sørensen P; Josefsson AM; Magnusson PK; Andersen PK; Pontén J; Adami HO; Gyllensten UB; Melbye M
Lancet; 2000 Jun; 355(9222):2194-8. PubMed ID: 10881892
[TBL] [Abstract][Full Text] [Related]
2. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study.
Josefsson AM; Magnusson PK; Ylitalo N; Sørensen P; Qwarforth-Tubbin P; Andersen PK; Melbye M; Adami HO; Gyllensten UB
Lancet; 2000 Jun; 355(9222):2189-93. PubMed ID: 10881891
[TBL] [Abstract][Full Text] [Related]
3. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ.
Moberg M; Gustavsson I; Gyllensten U
Int J Cancer; 2004 Dec; 112(5):854-9. PubMed ID: 15386375
[TBL] [Abstract][Full Text] [Related]
4. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.
Ylitalo N; Josefsson A; Melbye M; Sörensen P; Frisch M; Andersen PK; Sparén P; Gustafsson M; Magnusson P; Pontén J; Gyllensten U; Adami HO
Cancer Res; 2000 Nov; 60(21):6027-32. PubMed ID: 11085523
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer.
Sundström K; Ploner A; Dahlström LA; Palmgren J; Dillner J; Adami HO; Ylitalo N; Sparén P
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):150-8. PubMed ID: 23155137
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of human papillomavirus and risk of cervical adenocarcinoma.
Dahlström LA; Ylitalo N; Sundström K; Palmgren J; Ploner A; Eloranta S; Sanjeevi CB; Andersson S; Rohan T; Dillner J; Adami HO; Sparén P
Int J Cancer; 2010 Oct; 127(8):1923-30. PubMed ID: 20473898
[TBL] [Abstract][Full Text] [Related]
7. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
[TBL] [Abstract][Full Text] [Related]
8. Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer.
Sundström K; Ploner A; Arnheim-Dahlström L; Eloranta S; Palmgren J; Adami HO; Ylitalo Helm N; Sparén P; Dillner J
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26160881
[TBL] [Abstract][Full Text] [Related]
9. [Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].
Levert M; Clavel C; Graesslin O; Masure M; Birembaut P; Quereux C; Gabriel R
Gynecol Obstet Fertil; 2000 Oct; 28(10):722-8. PubMed ID: 11244634
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus and the long-term risk of cervical neoplasia.
van der Graaf Y; Molijn A; Doornewaard H; Quint W; van Doorn LJ; van den Tweel J
Am J Epidemiol; 2002 Jul; 156(2):158-64. PubMed ID: 12117707
[TBL] [Abstract][Full Text] [Related]
11. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
[TBL] [Abstract][Full Text] [Related]
12. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
[TBL] [Abstract][Full Text] [Related]
13. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.
Liaw KL; Glass AG; Manos MM; Greer CE; Scott DR; Sherman M; Burk RD; Kurman RJ; Wacholder S; Rush BB; Cadell DM; Lawler P; Tabor D; Schiffman M
J Natl Cancer Inst; 1999 Jun; 91(11):954-60. PubMed ID: 10359548
[TBL] [Abstract][Full Text] [Related]
14. Dysplasia and HPV infection initially detected by DNA analysis in cytomorphologically normal cervical smears.
Saito J; Sumiyoshi M; Nakatani H; Ikeda M; Hoshiai H; Noda K
Int J Gynaecol Obstet; 1995 Oct; 51(1):43-8. PubMed ID: 8582517
[TBL] [Abstract][Full Text] [Related]
15. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.
Zielinski GD; Snijders PJ; Rozendaal L; Voorhorst FJ; van der Linden HC; Runsink AP; de Schipper FA; Meijer CJ
Br J Cancer; 2001 Aug; 85(3):398-404. PubMed ID: 11487272
[TBL] [Abstract][Full Text] [Related]
16. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia.
Villa LL; Sichero L; Rahal P; Caballero O; Ferenczy A; Rohan T; Franco EL
J Gen Virol; 2000 Dec; 81(Pt 12):2959-2968. PubMed ID: 11086127
[TBL] [Abstract][Full Text] [Related]
17. Using the number of koilocytes to predict HIV serostatus in women with HPV-associated SIL.
Branca M; Migliore G; Giuliani M; Morosini PL; Mudu P; Cappiello G; Garbuglia AR; Ippolito G; Rezza G;
Acta Cytol; 2000; 44(6):1000-4. PubMed ID: 11127727
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix.
Sundström K; Eloranta S; Sparén P; Arnheim Dahlström L; Gunnell A; Lindgren A; Palmgren J; Ploner A; Sanjeevi CB; Melbye M; Dillner J; Adami HO; Ylitalo N
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2469-78. PubMed ID: 20671136
[TBL] [Abstract][Full Text] [Related]
19. Detection and estimation of human papillomavirus viral load in patients with cervical lesions.
Rahman T; Tabassum S; Jahan M; Nessa A; Ashrafunnessa
Bangladesh Med Res Counc Bull; 2013 Aug; 39(2):86-90. PubMed ID: 24930198
[TBL] [Abstract][Full Text] [Related]
20. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study.
Molano M; Van den Brule A; Plummer M; Weiderpass E; Posso H; Arslan A; Meijer CJ; Muñoz N; Franceschi S;
Am J Epidemiol; 2003 Sep; 158(5):486-94. PubMed ID: 12936904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
